U.S. markets closed

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0000+0.1089 (+12.22%)
At close: 04:00PM EDT
1.0100 +0.01 (+1.00%)
After hours: 07:35PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.8911
Bid0.9500 x 1800
Ask1.0100 x 1400
Day's Range0.9500 - 1.0100
52 Week Range0.8800 - 8.3850
Avg. Volume169,979
Market Cap98.122M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.9650
Earnings DateAug 09, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SMMT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Summit Therapeutics Inc.
    Daily – Vickers Top Buyers & Sellers for 07/15/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    25 days agoArgus Research
View more
  • GlobeNewswire

    Summit Therapeutics’ Rights Offering Nearing Expiration Date

    Summit Provides Preliminary Update on Financial PositionMenlo Park, California, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern Daylight Time on August 8, 2022 (the “Expiration Date”). Importantly, for stockholders whose shares of our common stock are held in a brokerage account or are otherwise not registered directly with t

  • GlobeNewswire

    Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President

    Bob Duggan Remains Chairman of the Board of Directors and CEOMenlo Park, California, July 26, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Maky Zanganeh, DDS, MBA, has been appointed as Co-Chief Executive Officer & President, effective immediately. Dr. Zanganeh was formerly the Company’s Chief Operating Officer, having served in that capacity since she joined the Company as an employee in November 2020, and remains a member of the Company’s Board of Directo

  • GlobeNewswire

    Summit Therapeutics Announces Commencement of $100 Million Rights Offering

    Menlo Park, CA, July 18, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it has commenced its previously-announced rights offering of up to $100 million of the Company’s common stock. The subscription rights will expire and have no value if they are not exercised prior to 5:00 pm Eastern Time on August 8, 2022, the expiration date (the “Expiration Date”). Pursuant to the rights offering, Summit is distributing, at no charge to the holders of its common stock